MedPath

Study Of Bupropion SR (323U66) In Patients With Major Depressive Disorder In Japan

Phase 2
Completed
Conditions
Major Depressive Disorder (MDD)
Registration Number
NCT00330616
Lead Sponsor
GlaxoSmithKline
Brief Summary

This is a study to obtain clinical experience of 323U66 SR for elderly patients with depression in repeat-dose of 323U66 SR up to 300mg/day, and to conduct exploratory investigation on safety, efficacy and pharmacokinetics profile in elderly patients with depression.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
35
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change From Baseline in Hamilton Rating Scale for Depression (HAM-D) Total Score at Week 8Baseline and Week 8

The Hamilton Rating Scale for Depression (HAM D) contains 17 questions which detect change and measure illness severity. Individual items are rated on a scale of 0-4, 0-3, and 0-2 with total HAM D score range from 0 (not ill) to 53 (severely ill).

Secondary Outcome Measures
NameTimeMethod
Percentage Change From Baseline in Hamilton Rating Scale for Depression (HAM-D) Total Score at Week 4Baseline and Week 4

The Hamilton Rating Scale for Depression (HAM D)contains 17 questions which detect change and measure illness severity. Individual items are rated on a scale of 0-4, 0-3, and 0-2 with total HAM D score range from 0 (not ill) to 53 (severely ill).

Percentage Change From Baseline in Hamilton Rating Scale for Depression (HAM-D)Total Score at Week 8Baseline and Week 8

The Hamilton Rating Scale for Depression (HAM D)contains 17 questions which detect change and measure illness severity. Individual items are rated on a scale of 0-4, 0-3, and 0-2 with total HAM D score range from 0 (not ill) to 53 (severely ill).

Percentage of Responders Based on the Hamilton Rating Scale for Depression (HAM-D) at Week 4Week 4

The Hamilton Rating Scale for Depression (HAM D)contains 17 questions which detect change and measure illness severity. Individual items are rated on a scale of 0-4, 0-3, and 0-2 with total HAM D score range from 0 (not ill) to 53 (severely ill). Responders are defined as subjects that had a decrease of \>/= 50% total score on the HAM D.

Percentage of Responders Based on the Hamilton Rating Scale for Depression (HAM-D) at Week 8Week 8

The Hamilton Rating Scale for Depression (HAM D)contains 17 questions which detect change and measure illness severity. Individual items are rated on a scale of 0-4, 0-3, and 0-2 with total HAM D score range from 0 (not ill) to 53 (severely ill). Responders are defined as subjects that had a decrease of \>/= 50% total score on the HAM D.

Percentage of Remitters Based on the Hamilton Rating Scale for Depression (HAM-D) at Week 4Week 4

The Hamilton Rating Scale for Depression (HAM D)contains 17 questions which detect change and measure illness severity. Individual items are rated on a scale of 0-4, 0-3, and 0-2 with total HAM D score range from 0 (not ill) to 53 (severely ill). Remitters are defined as subjects with a HAM D total score of \</= 7.

Percentage of Remitters Based on the Hamilton Rating Scale for Depression (HAM-D) at Week 8Week 8

The Hamilton Rating Scale for Depression (HAM D)contains 17 questions which detect change and measure illness severity. Individual items are rated on a scale of 0-4, 0-3, and 0-2 with total HAM D score range from 0 (not ill) to 53 (severely ill). Remitters are defined as subjects with a HAM D total score of \</= 7.

Change From Baseline in Hamilton Rating Scale for Depression (HAM-D) of Each Question's Score at Week 4Baseline and Week 4

The Hamilton Rating Scale for Depression (HAM D)contains 17 questions which detect change and measure illness severity. Individual items are rated on a scale of 0-4, 0-3, and 0-2 with total HAM D score range from 0 (not ill) to 53 (severely ill).

Change From Baseline in Hamilton Rating Scale for Depression (HAM-D) for Each Question's Score at Week 8Baseline and Week 8

The Hamilton Rating Scale for Depression (HAM D)contains 17 questions which detect change and measure illness severity. Individual items are rated on a scale of 0-4, 0-3, and 0-2 with total HAM D score range from 0 (not ill) to 53 (severely ill).

Percentage of Change From Baseline in Hamilton Rating Scale for Depression (HAM-D)for Each Question's Score at Week 4Baseline and Week 4

The Hamilton Rating Scale for Depression (HAM-D)contains 17 questions which detect change and measure illness severity. Individual items are rated on a scale of 0-4, 0-3, and 0-2 with total HAM-D score range from 0 (not ill) to 53 (severely ill).

Percentage of Change From Baseline in Hamilton Rating Scale for Depression (HAM-D) for Each Question's Score at Week 8Baseline and Week 8

The Hamilton Rating Scale for Depression (HAM-D)contains 17 questions which detect change and measure illness severity. Individual items are rated on a scale of 0-4, 0-3, and 0-2 with total HAM D score range from 0 (not ill) to 53 (severely ill).

Hamilton Rating Scale for Depression (HAM-D) Total Score at Week 4 and Week 8Week 4 and Week 8

The Hamilton Rating Scale for Depression (HAM-D)contains 17 questions which detect change and measure illness severity. Individual items are rated on a scale of 0-4, 0-3, and 0-2 with total HAM D score range from 0 (not ill) to 53 (severely ill).

Percentage of Responders Based on the Clinical Global Impression - Global Improvement Score (CGI-I)at Week 4 and Week 8Week 4 and Week 8

The CGI-I assesses the investigator's impression of the patient's current illness. The time span is the week before the rating and the score ranges from 1 (very much improved) to 7 (very much worse). Responders are subjects that have a score of 1 (very much improved) or 2 (much improved) on the CGI-I.

Change From Baseline in Clinical Global Impression (CGI) Severity of Illness Score at Weeks 1, 2, 3, 4, 8Baseline, Weeks 1, 2, 3, 4, 8

The CGI-S assesses the investigator's impression of the severity of the patient's current illness. The time span is the week before the rating and the score ranges from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).

Adverse Events (>=5% Incidence)Baseline through Week 8
Serious Adverse EventsBaseline through Week 8

Trial Locations

Locations (1)

GSK Investigational Site

🇯🇵

Tokyo, Japan

© Copyright 2025. All Rights Reserved by MedPath